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Primary cardiac lymphomas represent an extremely rare entity of extranodal lymphomas and should be
distinguished from secondary cardiac involvement of disseminated lymphomas belonging to the non-Hodgkin’s
classification of blood cancers. Only 90 cases have been reported in literature. Presentation of cardiac lymphomas
on imaging studies may not be unambiguous since they potentially mimic other cardiac neoplasms including
myxomas, angiosarcoma or rhadomyomas and therefore require multimodality cardiac imaging, endomyocardial
biopsy, excisional intraoperative biopsy and pericardial fluid cytological evaluation to establish final diagnosis.
Herein we report the case of a 70 y/o immunocompetent Caucasian female with a rapidly progressing superior
vena cava syndrome secondary to a large primary cardiac diffuse large B cell lymphoma (NHL lymphoma) almost
completely obstructing the right atrium, right ventricle and affecting both mitral and tricuspid valve. The patient had
no clinical evidence of disseminated disease and was successfully treated with extensive debulking during open-heart
surgery on cardiopulmonary bypass and 6 cycles of rituximab, cyclophosphamide, doxorubicin, vincristine and
prednisone chemotherapy (R-CHOP).
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Primary malignant cardiac neoplasms are extremely rare
and among those primary lymphomas constitute only a
minor entity. By definition primary cardiac lymphomas
belong to the non-Hodgkin’s (NHLs) classification of
blood cancers since Hodgkin’s lymphomas seldom show
extranodal involvement. Based upon the data of 22 large
autopsy series reported by McAllister et al., the frequency
of primary cardiac tumors is approximately 0.02%,
corresponding to 200 tumors in 1 million autopsies
[1]. Metastasis to the heart from other primary cancers is
30 times more common [2]. Only 25% of primary cardiac
tumors are malignant and of these as few as 1.3% are
primary cardiac lymphomas [3]. Only 0.5% of all extranodal
lymphomas present as cardiac neoplasms [3]. Malignant
primary cardiac tumors have a dismal prognosis with a
survival rate of only 10% at 9 to 12 months [4]. In cases of
cardiac inflow obstruction at the time of presentation
early surgical debulking plays an important role for
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distribution, and reproduction in any mediumR-CHOP chemotherapy remains the mainstay of medical
treatment. While surgical intervention may initially be
necessary to maintain cardiac function the treatment
modality most likely to impact the natural history of
the disease is R-CHOP chemotherapy [4].Case presentation
A 70 y/o immunocompetent Caucasian female presented
with palpitations and arrhythmias. The patient’s cardiologist
could not detect any structural abnormalities on transtho-
racic echocardiography (Figure 1A 4-chamber view,
Figure 1B parasternal long axis, Figure 1C aortic root and
left atrial diameter measurement, Figure 1D parasternal
short axis). Within a period of only two weeks she
developed progressive dyspnea, facial edema and facial
erythema. Transthoracic echocardiography was repeated in
our institution and revealed on average 1 cm thick masses
on both surfaces of the leaflets of the tricuspid and mitral
valves, suggestive of a rapidly progressing underlying
pathology. To that point the patient’s past medical history
was significant for essential hypertension. There was no
history of chest pain, dyspnea or fever. The patient’s
cardiac examination revealed no murmurs or extra heart
sounds. The patient denied any use of tabaco or alcohol.ntral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Initial transthoracic echocardiography (TTE) study showing no structural abnormalities on all views. A 4-chamber view. Regular
ventricles and atria, no suspicious masses can be identified. Intact mitral and tricuspid valvular apparatus. B Parasternal long axis showing a regular,
non obstructed left ventricular outflow tract. Left Atrium, mitral valve with anterior and posterior leaflet, left ventricle, aortic valve and ascending aorta.
No ventricular wall dyskinesias, no obstructions. C Aortic root and left atrial diameter measurement. 35,5 mm versus 38.5 mm D Parasternal short axis.
Mitral valve level showing intact valvular apparatus, no vegetations can be identified.
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detectable on inspiration suggestive of an increased
jugular venous pressure.
A magnetic resonance imaging (MRI) scan revealed
heterogeneity of the right atrium right ventricle and left
atrium and raised concerns of a possible extensive mass
(Figure 2A axial view and Figure 2B sagittal view). A
transthoracic echocardiogram (TEE) was performed only 3
weeks after the initial transthoracic echocardiography study
(Figure 3A 5-chamber view, Figure 3B mid-esophageal
4-chamber view, Figure 3C mid esophageal long axis,Figure 2 Magnetic resonance imaging demonstrating no evidence of
showing both pericardial and bilateral pleural effusions, right greater than
intracavitary tumor formation, partially obstructing the right atrial and the r
intracavitary tumor formation and both pericardial and bilateral pleural effu
be observed.Figure 4D, 4-chamber view and additional file 1: Video 1)
and revealed a right atrial and right ventricular soft
tissue density, diffusely infiltrating both the lateral
right atrial wall and free wall of the right ventricle
with multisegmental dyskinesias, highly suspicious for a
malignant neoplasm. Due to diffuse infiltration the exact
tumor dimensions were difficult to calculate, however, the
mass was estimated to be 8 cm in total length with an area
index of 32 cm2 upon four-chamber view. The mass
appeared to partially occlude superior vena cava (SVC)
and inferior vena cava (IVC) flow but did not extend intomediastinal lymphadenopathy. A Axial view, T2 weighted images
left. Right ventricular wall irregularities and right greater than left
ight ventricular flow. B Sagittal view, T2 weighted images evidencing
sions. No evidence of mediastinal lymphadenopathy could
Figure 3 Repeat transesophageal echocardiography (TEE) study. A 5-chamber view. Tumor formation in both left and right sided cardiac
structures, mitral and tricuspid valves are affected. Of note, both, the right atrium and the right ventricle are significantly obstructed. B Mid-esophageal
4-chamber view confirming extensive tumor formation and showing significant involvement of the mitral valve leaflets. Both, the right atrium and the
right ventricle are severely obstructed. C Mid esophageal long axis confirming mitral valve involvement. D 4-chamber view, with cut apex. Tumor
formation on mitral valve, however mitral valve apparatus does not appear to be diffusely infiltrated or misconfigured.
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to be moderately dilated. Due to the extensive growth
of the mass right ventricular inflow and outflow tract
appeared to be significantly obstructed. There was a
functional tricuspid stenosis with a mean gradient of
12 mmHg. Both left atrium and left ventricle were normal
in size with an end diastolic left ventricular diameter
(LVEDD) of 39 mm, an end systolic left ventricular
diameter (LVESD) of 24 mm and a normal systolicFigure 4 Histology. Complete destructive replacement of the
myocardial wall by a diffuse large B cell lymphoma that
demonstrated plasmacytoid differentiation and blasts.function and normal ejection fraction. Of note, there
was tumor formation also in the left atrium affecting the
mitral valve. Additionally, the patient demonstrated both
pericardial effusion of up to 17 mm and bilateral pleural
effusions again raising concern of malignant transformation.
A PET scan was performed demonstrating pathologic
fluorodeoxyglucose (18 F-FDG) tracer uptake in the right
atrial wall, right ventricular wall and left atrium. Coronary
angiography revealed no abnormalities.
Due to pending SVC obstruction, the patient underwent
rapid surgical excision of the mass in open-heart surgery.
The operation was performed with inferior vena cava and
anonymous vein cannulation due to the fact that the SVC
was obstructed and a left ventricular vent via the right
superior pulmonary vein on cardiopulmonary bypass.
Myocardial protection was achieved with antegrade
aortic cardioplegia only. Both the right atrial and right
ventricular walls and cavitites consisted of dense, fibrotic
composition and tumor masses were palpable along the
right side of the heart. Intraoperatively no lumen was
detected in the right atrium. Only surgical debulking was
feasible as the entire right side of the heart appeared to
consist only of tumor mass. In order to create a new right
atrial cavity a pericardial patch was implanted and sewed
to the right atrial margins by means of 5–0 prolene suture.
The excised masses were of soft and homogeneous
composition. Frozen sections were sent for histopathologic
evaluation and revealed complete destructive replacement
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oma that demonstrated plasmacytoid differentiation
(non-Hodgkin’s lymphoma, Figure 4).
Further histological evaluation of morphology, immu-
nohistochemistry, conventional cytogenetics and in-situ
hybridization revealed high-grade CD20+, CD79a+,
BCL-2+ BCL-6+ and MUM-1+ blasts. Only 10% of tumor
cells showed c-MYC immunoreactivity. An additionally
performed in-situ hybridization for Epstein Barr Virus
(EBV) was negative.
Following surgery there was a grade I tricuspid insuffi-
ciency. The patient was off all inotropes and pressors on
postoperative day 2 and eventually discharged for further
oncologic treatment in good clinical condition with
normal ejection fraction and good right ventricular func-
tion. The patient was started on a standard chemotherapy
protocol of 6 cycles rituximab, cyclophosphamide, doxo-
rubicin, vincristine and prednisone (R-CHOP). However,
despite the highly malignant nature of the lymphoma the
regimen was initiated only after a time span of 2 weeks after
surgery due to major concerns of potential ventricular
rupture as the neoplasm was diffusely infiltrating cardiac
structures including the entire free wall of the right
ventricle. Post-surgical adhesions between the heart
and the pericardial sac were thought to prevent major
bleedings beyond this 2-week period.
Discussion
Primary cardiac lymphomas are rare neoplasms and
comprise 1.3% of all cardiac tumors [3]. To date, fewer
than 90 tumors have been described in literature, mostly
as single case reports [5].
Primary cardiac lymphomas must be distinguished
from other primary malignant tumors of the heart
such as angiosarcomas (the most common primary
malignancy of the heart) and from the more common
benign cardiac tumors such as myxomas and lipomas.
Because diffuse large B cell lymphomas, are highly
malignant and aggressive neoplasms, prompt diagnosis
and therapy (chemotherapy and surgery) are key factors for
favorable clinical outcomes. Of note, diffuse large B cell
lymphomas are extremely fast growing neoplasms. As in
the case of our patient no structural abnormalities could be
detected upon the initial transthoracic echocardiography
study, however, manifestation of the tumor progressed to
both impressive and dramatic dimensions within only two
weeks’ time and prompted for rapid surgery.
Cardiac tumors have been called the great mimickers,
symptom-wise and diagnostic-wise. Symptom-wise, no
pathognomic features exist and cardiac neoplasms may
present with chest pain, arrhythmias, superior vena cava
syndrome if in an intracavitary localization and obstructing
venous flow, thrombus formation and peripheral embolism,
intractable heart failure, pericardial effusion or suddencardiac death and classic constitutional symptoms such as
fever, malaise and weight loss. Diagnostic-wise, presentation
of cardiac lymphoma on imaging studies may not be
unambiguous since they potentially mimic other cardiac
neoplasms including myxomas, angiosarcoma or rhadomyo-
mas. Therefore, diagnosis of cardiac tumors vitally depends
on the use of multiple imaging techniques, including cardiac
magnetic resonance imaging (MRI), cardiac computed
tomography (CT), positron emission tomography (PET) or
fusion of the latter two (PET-CT). This imaging approach
is complemented with the use of endomyocardial biopsy,
excisional intraoperative biopsy and pericardial fluid
cytological evaluation to establish definitive diagnosis.
Conclusion
When possible, surgical excision in combination with
systemic chemotherapy remains the gold standard of
treatment for primary malignant cardiac tumors. Cardiac
tumors are the great mimickers; therefore multimodality
cardiac imaging is the key to early diagnosis and favorable
patient outcome.
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